Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Toho Holdings CoFRA:TON +3.81%32 Debt-to-EBITDA is 0.32 as of Mar. 2026, which is 73% below its 10-year median of 1.18. GuruFocus rates FRA:TON with a GF Score™ of 32/100 and a GF Value™ of €25.57 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 90 Medical Distribution companies, Toho Holdings Co ranks better than 86.67% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Toho Holdings Co's Debt-to-EBITDA or its related term are showing as below:
FRA:TON'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.31 Med: 1.18 Max: 2.56
Current: 0.31
During the past 13 years, the highest Debt-to-EBITDA Ratio of Toho Holdings Co was 2.56. The lowest was 0.31. And the median was 1.18.
FRA:TON's Debt-to-EBITDA is ranked better than 86.67% of 90
companies
in the Medical Distribution industry
Industry Median: 2.45
vs FRA:TON: 0.31
Toho Holdings Co (FRA:TON) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Toho Holdings Co Debt-to-EBITDA Related Terms
Toho Holdings Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Toho Holdings Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:TON vs MCK, CAH, COR: Debt-to-EBITDA Comparison
For the Medical Distribution subindustry, Toho Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Toho Holdings Co Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Toho Holdings Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Toho Holdings Co (FRA:TON) has a Debt-to-EBITDA of 0.32 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Toho Holdings Co. This is 73% below median its historical median of 1.18. Over the past decade, Toho Holdings Co's Debt-to-EBITDA has ranged from 0.31 to 2.56. According to the industry distribution chart, Toho Holdings Co ranks #12 out of 90 companies in the Medical Distribution industry, placing it in the top 13.3%.
Is Toho Holdings Co's Debt-to-EBITDA too high?
Toho Holdings Co's current Debt-to-EBITDA of 0.32 is 73% below median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 2.56. The Medical Distribution industry median Debt-to-EBITDA is 2.45. Toho Holdings Co's value of 0.32 is 86.9% below this industry median. Based on the distribution chart, Toho Holdings Co ranks #12 out of 90 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Toho Holdings Co has a GF Score™ of 32/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's Debt-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #12 out of 90 companies for Debt-to-EBITDA. This places Toho Holdings Co in the top 13% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.45. Toho Holdings Co's value of 0.32 is 86.9% below this benchmark. Historically, Toho Holdings Co's own Debt-to-EBITDA has ranged from 0.31 to 2.56 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 2.45, Toho Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.45, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Toho Holdings Co's current Debt-to-EBITDA of 0.32 is 86.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Toho Holdings Co. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current Debt-to-EBITDA is 0.32, which is 73% below median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Toho Holdings Co (FRA:TON) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.57, compared to a current price of €21.80 — trading 14.7% below its estimated fair value. The current Debt-to-EBITDA is 0.32, which is 73% below median its 10-year median of 1.18 and 86.9% below the Medical Distribution industry median of 2.45. Toho Holdings Co's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current Debt-to-EBITDA is 0.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Toho Holdings Co (FRA:TON) Overvalued in 2026?
Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued.
The current stock price of €21.80 is trading 14.7% below its estimated GF Value™ of €25.57.
GuruFocus considers Toho Holdings Co to be Modestly Undervalued.
Key valuation signals for FRA:TON:
Debt-to-EBITDA: 0.32 (73% below median its 10-year median of 1.18)
GF Value™: €25.57 vs. price of €21.80 (14.7% below fair value)
Industry Position: 86.9% below the Medical Distribution median (#12 of 90)
No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
32GF Score
Get the complete analysis for FRA:TON
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TON has been successfully added to your 
